abnormal somatic nervous system physiology_Slc12a5<tm1Tjj>/Slc12a5<tm1Tjj>

http://metadb.riken.jp/0005423E129X1SvJorI129X1SvJC57BL6orI129X1SvJNMRISlc12a5tm1TjjSlc12a5tm1TjjSlc12a5tm1Tjj

abnormal somatic nervous system physiology_Slc12a5<tm1Tjj>/Slc12a5<tm1Tjj>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• solute carrier family 12, member 5
  http://metadb.riken.jp/db/mgi_rdf/MGI:1862037

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Slc12a5<tm1Tjj>/Slc12a5<tm1Tjj>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Slc12a5<tm1Tjj>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI)

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• abnormal somatic nervous system physiology
  http://purl.obolibrary.org/obo/MP_0005423

文献

http://purl.org/net/cito/citesAsAuthority

• C A. Hübner, et.al., Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition., Neuron, 2001, 30
  http://rdf.ncbi.nlm.nih.gov/pubmed/11395011